Literature DB >> 8900904

Serological markers identify histologically latent coeliac disease among first-degree relatives.

H Vazquez1, A Cabanne, E Sugai, A Fiorini, S Pedreira, E Mauriño, E Smecuol, R Dezi, S Niveloni, J Valero, S De Rosa, N Litwin, Z Kogan, L A Boerr, J C Bai.   

Abstract

BACKGROUND AND AIM: Serological markers detect asymptomatic coeliac disease among first-degree relatives of patients with sprue. However, some relatives with coeliac disease-related antibodies have 'normal' jejunal mucosa by conventional histology. Whether these serological abnormalities represent false-positives or are consequences of gluten sensitivity is not known. Our aim was to evaluate, through quantitative histology, intestinal biopsies of asymptomatic relatives of probands seeking abnormalities consistent with latent coeliac disease. MATERIALS: Fifty-nine intestinal biopsies obtained from asymptomatic relatives were evaluated; 40 samples were suitable for histological quantification. Seven samples showed severe mucosal atrophy (coeliac disease) and 33 were considered as 'normals'. In the 'normal' group, nine samples were obtained from patients with one or more positive serological tests and 24 from those with negative tests. Morphometry was compared for samples obtained from healthy control individuals (n = 10) and for those from coeliac patients (n = 7).
METHODS: Serological tests used were: antigliadin antibodies type immunoglobulin (Ig)A and IgG (enzyme-linked immunosorbent assay), antirrecticulin antibody (immuno-fluorescence) and endomysial antibody (immunofluorescence). Biopsy samples were obtained with endoscopic forceps from the distal duodenum (second portion). Quantitative histology of duodenal biopsies was performed with a computerized image analysis system.
RESULTS: Relatives with positive serology showed shorter villi (P < 0.05) and higher number (P < 0.01) and numerical density (P < 0.01) of intraepithelial lymphocytes in crypts than healthy controls. Numerical density of intraepithelial lymphocytes in crypts in antibody-positive patients was significantly higher than that observed in relatives with negative serology (P < 0.03). Four of nine (44%) relatives with positive serology had a number of intraepithelial lymphocytes in crypts within the range of coeliac disease patients. However, only one patient with negative serology (4%) was in this range.
CONCLUSION: Our study shows quantitative histological evidence that relatives of probands with positive coeliac disease-related serology are not false-positives, and that they should be considered as individuals with latent coeliac sprue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900904     DOI: 10.1097/00042737-199601000-00005

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  7 in total

1.  Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group.

Authors:  C Farré; P Humbert; P Vilar; V Varea; X Aldeguer; J Carnicer; M Carballo; M A Gassull
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 2.  Do you still need a biopsy to diagnose celiac disease?

Authors:  S Guandalini; P Gupta
Journal:  Curr Gastroenterol Rep       Date:  2001-10

3.  Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease.

Authors:  A Granito; L Muratori; P Muratori; M Guidi; M Lenzi; F B Bianchi; U Volta
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

4.  [1997 gastroenterology update--I].

Authors:  W Fischbach; S S Gro; J Schölmerich; C Ell; P Layer; W E Fleig; H Zirngibl
Journal:  Med Klin (Munich)       Date:  1998-02-15

5.  Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant?

Authors:  S Mahadeva; J I Wyatt; P D Howdle
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

Review 6.  Risk factors in familial forms of celiac disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

7.  [Celiac disease in close family members].

Authors:  J Vergara Hernández; M Núñez Gómez de Tejada; R M Jiménez Castillo
Journal:  Aten Primaria       Date:  2005-03-15       Impact factor: 1.137

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.